Despite compelling evidence demonstrating an immune evasive function for tumour-expressed FasL, controversy surrounds this protein (O'Connell et al, 2001; Restifo, 2000), with some reports suggesting that FasL expression by tumour cells is proinflammatory and accelerates tumour elimination. This evidence concerns the gene FASLG and neoplasm.